# Alcohol: Thiamine and or Magnesium 1

> **NCT03466528** · PHASE2,PHASE3 · COMPLETED · sponsor: **Glasgow Royal Infirmary** · enrollment: 127 (actual)

## Conditions studied

- Alcohol Withdrawal
- Lactic Acidosis
- Vitamin B1 Deficiency
- Magnesium Deficiency
- Wernicke Encephalopathy

## Interventions

- **DRUG:** Magnesium Sulfate
- **DRUG:** Pabrinex

## Key facts

- **NCT ID:** NCT03466528
- **Lead sponsor:** Glasgow Royal Infirmary
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-12-16
- **Primary completion:** 2018-04-02
- **Final completion:** 2018-06-19
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2019-07-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03466528

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03466528, "Alcohol: Thiamine and or Magnesium 1". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03466528. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
